A detailed history of Tower Bridge Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Tower Bridge Advisors holds 40,003 shares of ABBV stock, worth $7.14 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
40,003
Previous 38,103 4.99%
Holding current value
$7.14 Million
Previous $6.54 Billion 20.88%
% of portfolio
0.82%
Previous 0.73%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$163.84 - $199.33 $311,296 - $378,727
1,900 Added 4.99%
40,003 $7.9 Billion
Q1 2024

Apr 29, 2024

SELL
$159.82 - $182.1 $572,635 - $652,464
-3,583 Reduced 8.6%
38,103 $6.94 Billion
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $20,915 - $23,555
-152 Reduced 0.36%
41,686 $6.46 Billion
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $38,340 - $44,384
287 Added 0.69%
41,838 $6.24 Billion
Q2 2023

Jul 20, 2023

SELL
$132.51 - $164.9 $1.83 Million - $2.28 Million
-13,848 Reduced 25.0%
41,551 $5.6 Billion
Q1 2023

Apr 26, 2023

SELL
$144.61 - $166.54 $141,717 - $163,209
-980 Reduced 1.74%
55,399 $8.83 Billion
Q4 2022

Jan 27, 2023

SELL
$138.31 - $165.87 $41,493 - $49,761
-300 Reduced 0.53%
56,379 $9.11 Billion
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $207,891 - $238,437
-1,549 Reduced 2.66%
56,679 $7.61 Billion
Q2 2022

Jul 21, 2022

SELL
$137.62 - $174.96 $525,846 - $668,522
-3,821 Reduced 6.16%
58,228 $8.92 Billion
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $224,365 - $278,375
1,700 Added 2.82%
62,049 $10.1 Billion
Q4 2021

Feb 09, 2022

SELL
$107.43 - $135.93 $422,951 - $535,156
-3,937 Reduced 6.12%
60,349 $8.17 Billion
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $258,764 - $293,736
2,432 Added 3.93%
64,286 $6.93 Billion
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $467,132 - $520,412
4,440 Added 7.73%
61,854 $6.97 Billion
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $381,272 - $419,734
3,727 Added 6.94%
57,414 $6.21 Billion
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $2.12 Million - $2.87 Million
26,365 Added 96.5%
53,687 $5.75 Billion
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $7,731 - $9,074
90 Added 0.33%
27,322 $2.39 Billion
Q2 2020

Jul 22, 2020

SELL
$73.37 - $98.18 $5,135 - $6,872
-70 Reduced 0.26%
27,232 $2.67 Billion
Q1 2020

Apr 27, 2020

SELL
$64.5 - $97.79 $11,610 - $17,602
-180 Reduced 0.65%
27,302 $2.08 Billion
Q4 2019

Feb 05, 2020

BUY
$72.13 - $90.25 $25,245 - $31,587
350 Added 1.29%
27,482 $2.43 Billion
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $305,453 - $367,242
-4,850 Reduced 15.16%
27,132 $2.31 Billion
Q2 2019

Aug 06, 2019

SELL
$65.7 - $83.98 $26,280 - $33,592
-400 Reduced 1.24%
31,982 $2.33 Billion
Q1 2019

Apr 30, 2019

BUY
$77.14 - $90.79 $310,951 - $365,974
4,031 Added 14.22%
32,382 $2.61 Billion
Q4 2018

Feb 07, 2019

SELL
$77.85 - $96.01 $120,667 - $148,815
-1,550 Reduced 5.18%
28,351 $2.61 Billion
Q3 2018

Oct 23, 2018

SELL
$88.91 - $98.84 $128,386 - $142,724
-1,444 Reduced 4.61%
29,901 $2.83 Billion
Q2 2018

Aug 09, 2018

SELL
$89.78 - $106.23 $36,001 - $42,598
-401 Reduced 1.26%
31,345 $2.9 Billion
Q1 2018

May 02, 2018

SELL
$92.01 - $123.21 $311,637 - $417,312
-3,387 Reduced 9.64%
31,746 $3 Billion
Q4 2017

Jan 30, 2018

BUY
$89.56 - $98.21 $3,582 - $3,928
40 Added 0.11%
35,133 $3.4 Billion
Q3 2017

Nov 06, 2017

BUY
$69.85 - $89.22 $2.45 Million - $3.13 Million
35,093
35,093 $3.12 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tower Bridge Advisors Portfolio

Follow Tower Bridge Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Bridge Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Tower Bridge Advisors with notifications on news.